{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:02:54Z","timestamp":1784599374545,"version":"3.55.0"},"reference-count":34,"publisher":"ARAN Ediciones","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hipertensi\u00f3n y Riesgo Vascular"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.hipert.2024.08.001","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T13:23:20Z","timestamp":1728566600000},"page":"43-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Update on the diagnosis of the pheochromocytoma"],"prefix":"10.20960","volume":"42","author":[{"given":"E.","family":"Achote","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.F.","family":"Arroyo Ripoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Araujo-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8588","reference":[{"key":"10.1016\/j.hipert.2024.08.001_bib0175","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.hipert.2024.08.001_bib0180","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting","year":"2021","journal-title":"Endocr Rev"},{"key":"10.1016\/j.hipert.2024.08.001_bib0185","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMra1806651","article-title":"Pheochromocytoma and paraganglioma","volume":"381","author":"Neumann","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hipert.2024.08.001_bib0190","doi-asserted-by":"crossref","first-page":"T201","DOI":"10.1530\/ERC-18-0085","article-title":"65 years of the double helix: genetics informs precision practice in the diagnosis and management of pheochromocytoma","volume":"25","author":"Neumann","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.hipert.2024.08.001_bib0195","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.urology.2016.10.012","article-title":"Preoperative levels of catecholamines and metanephrines and intraoperative hemodynamics of patients undergoing pheochromocytoma and paraganglioma resection","volume":"100","author":"Weingarten","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.hipert.2024.08.001_bib0200","article-title":"Pheochromocytoma. Preoperative approach","author":"Araujo-Castro","year":"2024","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.hipert.2024.08.001_bib0205","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"Endocr Soc"},{"key":"10.1016\/j.hipert.2024.08.001_bib0210","unstructured":"Protocolo diagn\u00f3stico ante la sospecha de feocromocitoma \u2013 Medicine n.d. https:\/\/www.medicineonline.es\/es-protocolo-diagnostico-ante-la-sospecha-d-articulo-S0304541224001756 [accessed 5.8.24]."},{"key":"10.1016\/j.hipert.2024.08.001_bib0215","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/jch.14779","article-title":"Clinical diagnosis of pheochromocytoma and paraganglioma-induced secondary hypertension through UPLC-MS\/MS analysis of plasma catecholamines and their metabolites","volume":"26","author":"Zhang","year":"2024","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.hipert.2024.08.001_bib0220","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/clinchem\/hvab064","article-title":"Diagnostic accuracy of salivary metanephrines in pheochromocytomas and paragangliomas","volume":"67","author":"Eijkelenkamp","year":"2021","journal-title":"Clin Chem"},{"key":"10.1016\/j.hipert.2024.08.001_bib0225","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cca.2018.12.019","article-title":"Reference intervals for LC\u2013MS\/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine","volume":"490","author":"Eisenhofer","year":"2019","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.hipert.2024.08.001_bib0230","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2018.291369","article-title":"Biochemical diagnosis of chromaffin cell tumors in patients at high and low risk of disease: plasma versus urinary free or deconjugated O-methylated catecholamine metabolites","volume":"64","author":"Eisenhofer","year":"2018","journal-title":"Clin Chem"},{"key":"10.1016\/j.hipert.2024.08.001_bib0235","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1007\/s00216-020-02436-8","article-title":"Simple, rapid, and cost-effective microextraction by the packed sorbent method for quantifying of urinary free catecholamines and metanephrines using liquid chromatography\u2013tandem mass spectrometry and its application in clinical analysis","volume":"412","author":"Xiong","year":"2020","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.hipert.2024.08.001_bib0240","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1210\/jc.2002-021251","article-title":"A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-h urinary metanephrines and catecholamines","volume":"88","author":"Sawka","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hipert.2024.08.001_bib0245","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1210\/endrev\/bnad011","article-title":"Biochemical assessment of pheochromocytoma and paraganglioma","volume":"44","author":"Eisenhofer","year":"2023","journal-title":"Endocr Rev"},{"key":"10.1016\/j.hipert.2024.08.001_bib0250","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12020-017-1300-y","article-title":"Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review","volume":"56","author":"D\u00e4rr","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.hipert.2024.08.001_bib0255","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4158\/EP13251.OR","article-title":"Plasma free metanephrine and normetanephrine levels are increased in patients with chronic kidney disease","volume":"20","author":"Niculescu","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/j.hipert.2024.08.001_bib0260","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1161\/HYPERTENSIONAHA.122.19019","article-title":"Improved diagnostic accuracy of clonidine suppression testing using an age-related cutoff for plasma normetanephrine","volume":"79","author":"Remde","year":"2022","journal-title":"Hypertens (Dallas, Tex 1979)"},{"key":"10.1016\/j.hipert.2024.08.001_bib0265","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/cen.14724","article-title":"Clonidine suppression test for a reliable diagnosis of pheochromocytoma: when to use","volume":"97","author":"Tsiomidou","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.hipert.2024.08.001_bib0270","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1007\/s40618-021-01649-7","article-title":"Protocol for presurgical and anesthetic management of pheochromocytomas and sympathetic paragangliomas: a multidisciplinary approach","volume":"44","author":"Araujo-Castro","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.hipert.2024.08.001_bib0275","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2967\/jnumed.120.259689","article-title":"Imaging of pheochromocytoma and paraganglioma","volume":"62","author":"Carrasquillo","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.hipert.2024.08.001_bib0280","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.endinu.2021.09.013","article-title":"Role of imaging test with radionuclides in the diagnosis and treatment of pheochromocytomas and paragangliomas","volume":"69","author":"Araujo-Castro","year":"2022","journal-title":"Endocrinol Diabetes Nutr"},{"key":"10.1016\/j.hipert.2024.08.001_bib0285","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12020-015-0544-7","article-title":"The incremental benefit of functional imaging in pheochromocytoma\/paraganglioma: a systematic review","volume":"50","author":"Brito","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.hipert.2024.08.001_bib0290","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2967\/jnumed.118.211706","article-title":"Performance of 68Ga-DOTA-conjugated somatostatin receptor-targeting peptide pet in detection of pheochromocytoma and paraganglioma: a systematic review and metaanalysis","volume":"60","author":"Han","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.hipert.2024.08.001_bib0295","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s00259-019-04398-1","article-title":"European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"46","author":"Ta\u00efeb","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.hipert.2024.08.001_bib0300","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00441-018-2795-0","article-title":"Chromaffin cell biology: inferences from The Cancer Genome Atlas","volume":"372","author":"Fishbein","year":"2018","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.hipert.2024.08.001_bib0305","first-page":"21","article-title":"Hereditary syndromes in neuroendocrine tumors","author":"Lewis","year":"2020","journal-title":"Curr Treat Opt Oncol"},{"key":"10.1016\/j.hipert.2024.08.001_bib0310","first-page":"14","article-title":"Pheochromocytoma\/paraganglioma-associated cardiomyopathy","author":"Szatko","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.hipert.2024.08.001_bib0315","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijcard.2022.08.053","article-title":"A systematic cohort review of pheochromocytoma-induced typical versus atypical Takotsubo cardiomyopathy","volume":"371","author":"Aw","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hipert.2024.08.001_bib0320","article-title":"Pheochromocytoma as a simulator of cardiac pathology","author":"Vallejo Herrera","year":"2024","journal-title":"Hipertens Riesgo Vasc"},{"key":"10.1016\/j.hipert.2024.08.001_bib0325","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.hipert.2022.11.004","article-title":"Ischemic cardiomyopathy as a presentation of pheocromocytoma","volume":"40","author":"Costas Eimil","year":"2023","journal-title":"Hipertens Riesgo Vasc"},{"key":"10.1016\/j.hipert.2024.08.001_bib0330","first-page":"41","article-title":"Seventy years of pheochromocytomas and paragangliomas in Argentina. The FRENAR database","author":"de Miguel","year":"2024","journal-title":"Hipertens Riesgo Vasc"},{"key":"10.1016\/j.hipert.2024.08.001_bib0335","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/HJH.0000000000003596","article-title":"Risk factors for intraoperative hypertensive crisis in patients with pheochromocytomas and sympathetic paragangliomas","volume":"42","author":"Araujo-Castro","year":"2024","journal-title":"J Hypertens"},{"key":"10.1016\/j.hipert.2024.08.001_bib0340","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijcard.2017.07.014","article-title":"Pheochromocytoma as a reversible cause of cardiomyopathy: analysis and review of the literature","volume":"249","author":"Zhang","year":"2017","journal-title":"Int J Cardiol"}],"container-title":["Hipertensi\u00f3n y Riesgo Vascular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1889183724000928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1889183724000928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:15:42Z","timestamp":1784596542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1889183724000928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1889183724000928"],"URL":"https:\/\/doi.org\/10.1016\/j.hipert.2024.08.001","relation":{},"ISSN":["1889-1837"],"issn-type":[{"value":"1889-1837","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on the diagnosis of the pheochromocytoma","name":"articletitle","label":"Article Title"},{"value":"Hipertensi\u00f3n y Riesgo Vascular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hipert.2024.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 SEH-LELHA. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}